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skeletal muscle fibres form by fusion of mesoderm progenitors called myoblasts. After birth, 
muscle fibres do not increase in number but continue to grow in size because of fusion of satellite 
cells, the postnatal myogenic cells, responsible for muscle growth and regeneration. numerous 
studies suggest that, on transplantation, non-myogenic cells also may contribute to muscle 
regeneration. However, there is currently no evidence that such a contribution represents a 
natural developmental option of these non-myogenic cells, rather than a consequence of 
experimental manipulation resulting in cell fusion. Here we show that pericytes, transgenically 
labelled with an inducible Alkaline Phosphatase CreERT2, but not endothelial cells, fuse with 
developing myofibres and enter the satellite cell compartment during unperturbed postnatal 
development. This contribution increases significantly during acute injury or in chronically 
regenerating dystrophic muscle. These data show that pericytes, resident in small vessels of 
skeletal muscle, contribute to its growth and regeneration during postnatal life. 
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Satellite cells are myogenic stem/progenitor cells of postnatal skeletal muscle and have a prominent role in tissue growth and regeneration. Recent work has demonstrated that, like 
embryonic myoblasts, most, if not all, satellite cells in the body 
originate from the Pax3 + /Pax7 +  cells in the somites and become 
detectable in their specific niche, underneath the basement mem-
brane of skeletal muscle fibres, from approximately E16.5 in the 
mouse1–4. However, numerous reports indicate that, on transplan-
tation, cells from tissues other than muscle (for example, bone 
marrow, brain, adipose tissue and blood vessels) can fuse with 
regenerating muscle fibres and also contribute to the satellite cell 
pool5–8. It is therefore important to understand whether contribu-
tion to skeletal muscle by non-myogenic progenitors is restricted 
to artificial conditions created by transplantation, or whether it 
occurs during unperturbed pre- and post-natal development. To 
address this question, we used a Cre-loxP lineage tracing strat-
egy to follow the in vivo fate of progenitors associated with the 
vasculature. Recently, we reported that pericytes associated with 
the micro-vasculature of human muscle are able to differentiate 
into skeletal muscle in vitro and in vivo, on transplantation into 
dystrophic, immune-deficient mice9. A major problem in peri-
cyte biology is the lack of specific markers10. Thus, we chose alka-
line phosphatase (AP) that, in contrast to other pericyte markers 
such as the neuro-glial 2 proteoglycan (NG2)11 or platelet-derived 
growth factor receptor beta (PDGFRβ)12, is not expressed in skel-
etal muscle fibres, nor in myogenic progenitors, but is restricted 
to the micro-vasculature of striated muscle in postnatal life. This 
strategy allowed us to label a subset of pericytes and endothelial 
cells, as in the mouse both of these cell types express AP. A second 
reporter mouse Tg:VE-Cadherin(PAC)-CreERT2 (ref. 13) allowed 
us to selectively follow endothelial cell fate inside skeletal muscle. 
Our data show that during postnatal growth, pericytes, but not 
endothelial cells, contribute to fibre development and to the sat-
ellite cell pool and, that this contribution is further enhanced by 
acute or chronic tissue regeneration.
Results
Alkaline phosphatase is expressed in muscle microvessels. In 
preliminary studies, we examined in great detail the expression 
of AP in postnatal and adult skeletal muscle. AP expression is 
robust and widespread in tissues such as intestine, bone and 
liver, whereas it is restricted to the micro-vasculature of other 
tissues, such as striated muscles, in many species14–16 including 
human9. We performed extensive immunofluorescence, confocal 
analysis on adult and juvenile skeletal muscle to confirm AP 
expression in vessel-associated cells. Both AP +  endothelial cells 
and pericytes were unequivocally identified by their anatomical 
niche and by labelling with different antibodies that recognize 
either one or the other cell population (Fig. 1a–l; Supplementary 
Fig. S1a–c).
We never detected AP +  cells that are not associated with small 
vessels; on the other hand, less than 20% of total vessels express AP. 
The in vivo expression pattern of AP in postnatal skeletal muscle 
was also confirmed by analysing mice carrying one copy of the 
TN-APβgeo allele17. In this mouse strain, β-gal +  cells are only asso-
ciated with vessels, whereas myofibres and satellite cells are always 
unlabelled (Supplementary Fig. S1d).
In skeletal muscle, pericytes and satellite cells are often adjacent 
to each other18 (arrows in the Fig. 1m); however, AP was never 
detected in Pax7 +  or MyoD +  satellite cells at any time exam-
ined; an example at P7 is shown in Supplementary Figure S1e,f, 
respectively. These results were confirmed by enzymatic staining 
for AP on muscles sections from the Myf5nlacZ/ +  mouse (express-
ing nuclear β-gal only in Myf5 +  cells19) (Fig. 1n), even after 
cardiotoxin-induced regeneration (Supplementary Fig. S1g–j). 
Notably, AP activity was invariably detected outside the basement 
membrane encircling skeletal muscle fibres and co-localized with 
platelet endothelial cell adhesion molecule (Pecam)-positive ves-
sels (Fig. 1o). Moreover, in single myofibres isolated from EDL or 
Tibialis anterior (TA) of P30 Myf5nlacZ/ +  mice, satellite cells were 
found not to express AP during activation, proliferation or dif-
ferentiation (Supplementary Fig. S1k–m). In contrast, nonpuri-
fied primary cultures of skeletal muscle contained both AP +  and 
Myf5 +  cells, but double positive cells were never detected (Supple-
mentary Fig. S1n). Satellite cells-derived clones did not express AP 
during proliferation (5 days in vitro) or after differentiation (10 
days in vitro) (Supplementary Fig. S1o,p). Taken together, these 
results show that, in mouse postnatal skeletal muscle, AP is only 
expressed by a subset of vessel-associated cells, whereas myogenic 
cells and myofibres never express AP.
Tissue nonspecific alkaline phosphatase CreERT2 mice. Three 
isoforms of AP have been identified in mouse: the placental (P-AP) 
and the intestinal (I-AP) isoforms on chromosome 1, and tissue 
nonspecific AP (TN-AP) on chromosome 4. By RT–PCR with prim-
ers specific for the different isoforms20, we found that adult skeletal 
muscle express exclusively TN-AP (Supplementary Fig. S2a). To 
follow the fate of AP +  cells in postnatal skeletal muscle, we gener-
ated three transgenic Tg:TN-AP-CreERT2 mouse lines (#3; #6; #12) 
(Supplementary Fig. S2b,c). After crossing with R26R reporter, the 
three transgenic lines express similar efficiency of Cre recombina-
tion, with little variability among different animals. No signal out-
side AP +  cells was detected in any of the mouse lines. We chose, 
for the majority of subsequent experiments line #12, whose founder 
was more fertile. However, several crucial experiments, such as con-
tribution to muscle fibres, were repeated in the different lines, again 
with similar results.
To examine the efficiency of recombination during postnatal 
skeletal muscle development, we subcutaneously injected Tg:TN-
AP-CreERT2:R26R mice with tamoxifen for 3 consecutive days 
at P6, P7 and P8, and skeletal muscles were analysed 3 days after 
the last injection. Approximately 70% of AP +  vessels also express 
β-gal, indicating efficient recombination, and no β-gal + /AP-nega-
tive cells were detected (Fig. 2a). Whole-muscle X-gal staining 
revealed β-gal +  vessels as expected (Diaphragm and Quadriceps 
muscles are shown in Fig. 2b,c, respectively). Moreover we demon-
strated, on skeletal muscle sections from Tg:TN-AP-CreERT2 mice 
that also carry the R26NZG reporter21, that β-gal is expressed by both 
Pecam +  endothelial cells (Fig. 2d,e) and PDGFRβ +  (Fig. 2f,g) or 
NG2 +  (Fig. 2h–k) pericytes at a ratio of about 1:1 (quantification in 
Fig. 2l: 500 β-gal +  cells were analysed.). The same results were con-
firmed also with Tg:TN-AP-CreERT2:R26R mice. (Supplementary 
Fig. S2d,e). After control oil injections no β-gal signal was detected 
(Supplementary Fig. S2f,g).
To further validate this transgenic mouse model and to unequiv-
ocally rule out that the Cre recombinase might be activated by satel-
lite cells, we prepared single fibres and nonpurified cells suspension 
from skeletal muscle of Tg:TN-AP-CreERT2:R26R-EYFP mice. Both 
preparations were cultured for 5 days with 4-OH tamoxifen: no yel-
low fluorescent protein (YFP) positive cells were found in purified, 
cultured muscle fibres (Fig. 2m,n); whereas in nonpurified primary 
cultures both YFP and MyoD were expressed, but never in the same 
cell (Fig. 2o,p).
By RT–PCR, we showed that freshly isolated YFP +  cells from 
Tg:TN-AP-CreERT2:R26R-EYFP mice (killed 2 days after the last 
tamoxifen injection), express TN-AP but not Pax7 and Myf5 mes-
senger RNAs, as opposed to freshly isolated SM/C2.6 +  satellite cells 
from the same mice (Supplementary Fig. S2h). Moreover, quanti-
tative RT–PCR showed that YFP +  cells express high levels of Cre, 
while satellite cells isolated from the same mice do not (Supplemen-
tary Fig. S2i; as positive control, we used C2C12 cells infected with 
recombinant AAV-Cre). These results indicate that satellite cells and 
ARTICLE 

nATuRE CommunICATIons | DoI: 10.1038/ncomms1508
nATuRE CommunICATIons | 2:499 | DoI: 10.1038/ncomms1508 | www.nature.com/naturecommunications
© 2011 Macmillan Publishers Limited. All rights reserved.
their derivatives never express the transgenic TN-AP-CreERT2 con-
struct, both in vivo and in vitro.
AP-derived cells contribute to postnatal skeletal muscle. To 
analyse the fate of AP + /β-gal +  cells, Tg:TN-AP-CreERT2:R26R 
mice were genetically labelled as described above and were killed 
8 weeks later, at the end of their growth period. We detected sev-
eral areas with β-gal +  fibres in all muscles analysed (Quadriceps, 
Gastrocnemius and Biceps femoris muscles are shown in Fig. 3a–c). 
Skeletal muscle sections showed many β-gal +  muscle fibres together 
with β-gal +  vessels (Fig. 3d,e) and several β-gal + /MyHC +  fibres 
(Fig. 3f). β-gal expression was randomly distributed between 
fast and slow fibres. The highest percentage of β-gal +  myofibres 
(7.3 ± 1.2%) was observed in the Diaphragm whereas the lowest was 
in the TA muscle (0.6 ± 0.2%) (Fig. 3g). We also confirmed these 
results by assaying β-gal activity in homogenates from different 
muscles (Methods) (Fig. 3h). Similar results were obtained using 
Tg:TN-AP-CreERT2:R26NZG mice (Fig. 3i, quantification in Fig. 3g), 
where we could clearly detect blue nuclei inside skeletal muscle 
fibres (Fig. 3j,k), ruling out the possibility of nonspecific staining 
due to β-gal diffusion inside the tissue. Tamoxifen injections at P1, 
P2 and P3 resulted in high pup lethality and did not significantly 
increase the percentage of labelled myofibres, suggesting that the 
contribution of AP-expressing cells to skeletal muscle remains con-
stant in the first week of postnatal life. On the other hand, later 
tamoxifen injections, from P8 to 1 month of age, resulted in a pro-
gressively lower amount of β-gal +  fibres in adult life, indicating 
that the myogenic potential of AP +  cells decreases with subsequent 
mouse growth.
Next, we investigated whether AP +  cells might contribute to 
the satellite cell pool. To this end, muscles of Tg:TN-AP-CreERT2:
R26R mice were collected at different time points after tamoxifen 
induction. No β-gal + /Pax7 +  satellite cells were observed in vivo 
3 days after the last tamoxifen injection; moreover, freshly isolated 
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Figure 1 | AP expression in mouse postnatal skeletal muscle. (a–d) Immunofluorescence analysis on 1-month-old mouse muscle sections shows 
localization of AP within vessel-associated cells. (a) AP +  cells are stained in red, nuclei are stained in blue by DAPI (b) nG2 +  cells are stained in green, 
(c) Ve-Cadherin +  cells are stained in cyan, (d) merged image. (e–h) AP is expressed by PDGFRβ + /smA +  pericytes. (e) AP +  cells are stained in red, 
nuclei are stained in grey by DAPI, (f) PDGFRβ +  cells are stained in green, nuclei are stained in grey by DAPI (g) smA +  cells are stained in blue and  
nuclei in grey by DAPI, (h) merged image. (i–l) AP is expressed by Pecam +  endothelial cells, surrounded by an AP-negative pericyte. (i) AP +  cells are 
stained in red, nuclei are stained in grey by DAPI, (j) Pecam +  cells are stained in green, nuclei are stained in grey by DAPI, (k) nG2 +  cells are stained in 
blue, nuclei are stained in grey by DAPI, (l) merged image. (m) Immunostained TA muscle (15-days-old) shows a Pax7 +  satellite cell (green arrow),  
and an AP +  vessel-associated cell (red arrow); Laminin in magenta. We counted 170 AP + /Pax7 −  cells and 102 AP − /Pax7 +  cells in TA muscle and 438 
AP + /Pax7 −  cells and 138 AP − /Pax7 +  cells in Soleus muscle: no co-localization is detected. (n,o) Myf5nlacZ/ +  TA muscle sections stained for X-gal (blue) 
and AP (red); Pecam is stained brown in (o). (a–d) scale bar, 100 µm. (e–o) scale bar, 20 µm.
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satellite cells did not express β-gal activity. However, 1 week after 
tamoxifen injection, few double-positive satellite cells were iden-
tified in vivo (Fig. 4a) (0.19% of the total Pax7 +  cells in the TA 
and 2.5% in the Pectoralis). At later stages, the percentage of dou-
ble-positive Pax7 + /β-gal +  satellite cells progressively increased 
in all muscles analysed, reaching, for example, 25% of total Pax7 + 
cells at 1 month after tamoxifen injection in the Pectoralis muscle 
(Fig. 4b). An example of Pax7 + /β-gal +  satellite cells underneath 
the basal lamina of a β-gal-negative fibre is shown in Figure 4c–f. 
Quantifications of Pax7 + /β-gal +  satellite cells detected with time 
are shown in Figure 4g. Although the total number of Pax7 +  satel-
lite cells decreases with time, the number of double-positive Pax7 + / 
β-gal +  progressively increases, reaching a plateau at 3 weeks 
after tamoxifen induction; a detailed quantification for the Pecto-
ralis muscle is shown in Figure 4h. Interestingly, we found a higher 
number of double-positive Pax7 + /β-gal +  cells in the same muscles 
where we detected more β-gal +  fibres, suggesting that AP-derived 
cells contribute to skeletal muscle formation mainly by entering the 
satellite cell compartment, although direct fusion with developing 
muscle fibres may occur as well.
Muscle regeneration enhances AP +  pericyte myogenesis. Tg:TN-
AP-CreERT2:R26R mice were treated with tamoxifen at P6–P8 
and then injected with cardiotoxin in TA and Gastrocnemius mus-
cles at P30; three weeks after injury all treated muscles showed a 
strong increase in the percentage of β-gal +  fibres in comparison 
with the contralateral, uninjured muscle (Fig. 5a,b). A section at 
high magnification, showing centrally located nuclei, typical of 
regenerating fibres, is shown in Figure 5c; quantification is shown 
in Figure 5d. These experiments were confirmed with Tg:TN-
AP-CreERT2:R26R line #3 and using Tg:TN-AP-CreERT2:R26NZG 
mice (Fig. 5e).
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Figure 2 | Tg:TN-AP-CreERT2 mouse generation. (a) section of Diaphragm muscle from double heterozygous Tg:TN-AP-CreERT2:R26R mice stained for 
β-gal (blue) and grey (red) 72 h after tamoxifen injection. Double-positive β-gal + /AP +  vessels are clearly visible. High magnification in the inset. scale 
bar, 100 µm. (b,c) X-gal whole-mount staining of Diaphragm (b) and Quadriceps (c) from Tg:TN-AP-CreERT2:R26R mice, 72 h after last tamoxifen injection. 
(d–k) Tg:TN-AP-CreERT2:R26NZG Triceps muscle sections, 72 h after tamoxifen injection, stained with X-Gal and antibodies specific for the endothelial or 
pericyte lineages. (d,e) Two β-gal + /Pecam +  endothelial cells are visible (arrows). Pecam is stained in red, nuclei are counterstained with DAPI. scale 
bar, 20 µm. (f,g) Two β-gal + /PDGFRβ +  pericytes surrounding a small vessel. PDGFRβ is stained in green, nuclei are counterstained with DAPI. scale bar, 
20 µm. (h–k) A β-gal + /nG2 +  pericyte surrounding a small vessel. note that the pericyte is negative for the endothelial marker Pecam. nG2 is stained in 
green; Pecam in red; nuclei are counterstained with DAPI. scale bar: 20 µm. (l) Distribution of β-gal +  cells within the endothelial and pericyte populations 
for the Diaphragm muscle; 500 β-gal +  cells were analysed. (m,n) single fibre preparation from Tg:TN-AP-CreERT2:R26R-EYFP TA muscle cultured for  
5 days with 4-oH tamoxifen and stained with anti-myoD (red) and anti-GFP antibodies (green); DAPI in blue. no YFP +  cells were found in purified fibre 
preparations. scale bars, 50 µm (o,p) nonpurified cell suspension of TA muscle from Tg:TN-AP-CreERT2:R26R-EYFP mice, cultured for 5 days with 4-oH 
tamoxifen and stained for myoD (red) and GFP (green); DAPI in blue. scale bars, 50 µm.
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To investigate whether AP +  pericyte-derived satellite cells were 
able to support a second round of regeneration, six Tg:TN-AP-
CreERT2:R26NZG mice at 1 month of age were injected with cardio-
toxin in both TA, as described above. After three weeks, a second 
cardiotoxin injection (at the same dose) was performed in the right 
TA only. Mice killed 24 h after the second injection showed complete 
destruction of previously regenerated fibres (Fig. 5f), as compared 
with contralateral muscles that had received only one injection and 
appeared similar to what shown in Figure 5e. Mice killed after three 
extra weeks showed the presence of new β-gal + , centrally nucleated 
fibres (Fig. 5g).
Muscular dystrophy also enhances AP +  pericyte myogenesis. To 
test whether AP +  pericytes increase their contribution to skeletal 
muscle during the degeneration/regeneration cycles that charac-
terize the progression of muscular dystrophy, Tg:TN-AP-CreERT2:
R26R:αSG − / −  dystrophic pups and their heterozygous littermates 
Tg:TN-AP-CreERT2:R26R:αSG + / −  were injected with tamoxifen 
at P6–P8 and killed 2 months later. In dystrophic skeletal muscle, 
we observed a very high percentage of β-gal +  fibres, up to three 
times more than control mice (Fig. 6a,b). Skeletal muscle sections 
showed that the regenerated fibres robustly express β-gal (Fig. 6c; 
quantification in Fig. 6d).
AP +  pericyte myogenesis is minimal in adult muscle. Two- and 
three-month-old male Tg:TN-AP-CreERT2:R26R mice were treated 
intraperitoneally with tamoxifen for 3 consecutive days and, 1 week 
after tamoxifen injection, almost 70% of AP +  cells were β-gal + . 
β-gal expression always co-localized with Pecam +  or NG2 +  vessel- 
associated cells (Supplementary Fig. S3a,b).
Two months after tamoxifen injection, all muscles examined 
showed many β-gal +  vessels; in ~30% of treated mice, we detected 
very few β-gal +  fibres, only short fragments of which were labelled, 
suggesting focal contribution of few AP-derived cells during adult 
life (Supplementary Fig. S3c). Moreover, this minimal contribu-
tion did not significantly increase after cardiotoxin-induced regen-
eration (0.15 ± 0.1 in control TA and 0.93 ± 0.4 in cardiotoxin TA; 
n = 4) (Supplementary Fig. S3e–h; quantification in Supplementary 
Fig. S3d). The contribution did not increase even when mice were 
injected with tamoxifen for 5 consecutive days.
Endothelial cells do not contribute to postnatal myogenesis. As 
AP is expressed in both pericytes and endothelial cells, we inves-
tigated whether one or both cell types contribute to skeletal mus-
cle formation in vivo. Tg:VE-cadherin-(PAC)CreERT2:R26R mice13 
were injected at P6–P8 with tamoxifen. Because VE-Cadherin is 
expressed only in endothelial cells22, we could selectively follow the 
fate of these cells. Three days after induction, 87 ± 5% of total ves-
sels were β-gal +  (Fig. 7a) and remained β-gal +  even in the mouse 
adult life (Fig. 7b,c), indicating a very efficient recombination in 
this transgenic mouse strain. Neither satellite cells nor myofibres 
were labelled 3 days or 1 week after tamoxifen injection (Fig. 7d) or, 
most importantly, 1 or 2 months after tamoxifen injection, in any 
of the muscles analysed (Fig. 7e). This was also the case after mus-
cle regeneration induced by cardiotoxin injection (Fig. 7f,g). Taken 
together, these results indicate that in postnatal life, endothelial cells 
do not contribute to skeletal muscle growth or regeneration, nor to 
the satellite cell pool.
AP +  cells generate smooth or skeletal myogenic clones in vitro. 
To confirm a possible progressive recruitment of AP +  cells into the 
satellite cell compartment, YFP +  cells, isolated from Tg:TN-AP-
CreERT2:R26R-EYFP mice (Fig. 8a) at different time points (3 days, 
1 week, 1 and 2 months) after tamoxifen injection (P6–P8), were 
stained for Pax7 (Fig. 8c–e; quantification Fig. 8b). The percentage of 
double-positive Pax7 + /YFP +  cells progressively increased during 
the first month of life from 0%, 3 days after tamoxifen injection, to 
3.7 ± 1.4% after 1 week, and 25.7 ± 2.9% after 1 month, remaining at a 
similar level at 2 months (30.3 ± 5.2%). One month after cardiotoxin 
muscle injury, tamoxifen-treated mice showed a similar percentage 
of YFP +  cells co-expressing Pax7 (29.5 ± 5.4%) (Fig. 8b), suggesting 
that AP-derived satellite cells can self-renew and maintain a con-
stant contribution to the satellite cell pool. These results were con-
firmed by quantitative RT–PCR for Pax7 and Myf5 (Supplementary 
Fig. S4a). Surprisingly, AP-derived satellite cells did not express 
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Figure 3 | Cells derived from TN-AP +  pool contribute to skeletal muscle 
fibre development. (a–c) β-gal staining of three different muscles,  
2 months after tamoxifen injection: Quadriceps (a) Gastrocnemius (b), 
Biceps femoris (c). (d,e) Quadriceps muscle sections stained for β-gal; 
blue fibres (arrow) along with blue vessels (arrowhead) are visible. The 
sign ( + ) marks β-gal +  fibres, whereas the sign ( − ) marks fibres with 
very low or no β-gal expression. (f) Immunofluorescence on sections 
from the same muscles shown in (d) and in (e) stained with anti- 
β-gal (red), anti-myHC (green) and anti-Laminin (magenta) antibodies 
confirms the presence of β-gal positive fibres. scale bar, 100 µm.  
(g) Quantification of β-gal +  fibres counted on the total fibre number. 
Different muscles were analysed. number of experimental animals:  
n = 15 for Tg:TN-AP-CreERT2:R26R mice, black bars; n = 5 for Tg:TN-AP-
CreERT2:R26NZG, red bars. Error bars represent standard deviation.  
(h) β-gal activity measurement on muscle homogenates. standard curve 
was obtained by different dilutions of CMV-Cre-R26 and wt muscles. 
β-gal activity obtained 1 week after the last tamoxifen injection in TN-AP-
CreERT2:R26R mice (representing labelling of the vessels) was subtracted 
from the obtained values. QuA, Quadriceps; GAs, Gastrocnemius; TRIC, 
Triceps; PECT, Pectoralis; DIAPH, Diaphragm; ABD, Abdominal; BICF, Biceps 
femoris. number of experimental animals: n = 5. Error bars represent 
standard deviation. (i–k) muscle sections of Tg:TN-AP-CreERT2:R26NZG 
injected with tamoxifen at P6–P8 and killed 2 months later, stained with 
X-gal and Eosin. Arrows show β-gal +  nuclei inside skeletal muscle fibres; 
arrowhead shows β-gal +  nuclei of vessel-associated cells. scale bar, 
100 µm (i) or 20 µm (j,k).
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Myf5, suggesting that they may belong to the Pax7 + /Myf5 − , self-
renewing satellite cell population23.
To test the skeletal myogenic potential of AP-expressing vas-
cular progenitors, we analysed the ability of AP-derived cells to 
give rise to myogenic clones. YFP +  cells were isolated 1 week after 
tamoxifen induction (P6–P8) and plated at clonal density in 96 
multiwells (1 cell per well). On average, 10% of plated cells gave 
rise to clones and 30% of these clones contained MyHC-expressing 
myocytes and myotubes (Fig. 8f), indicating that AP-Cre + , vessel-
associated cells have a significant spontaneous myogenic potential 
after isolation. Most ( > 90%) of the remaining MyHC-negative 
clones expressed smooth muscle actin (SMA) (Fig. 8g), in agree-
ment with their pericyte origin and smooth muscle fate. This was 
confirmed by staining with an antibody recognizing the cytoskel-
etal protein SM22α, a smooth muscle-specific marker24 (Fig. 
8h); very few clones (less than 1%) contained both MyHC +  and 
SM22α +  cells (Fig. 8i), indicating that very few AP +  cells main-
tain a double potency, once isolated and cloned in vitro. Freshly 
isolated YFP +  cells express pericyte and endothelial genes such 
as Tie2, (endothelial-specific receptor tyrosine kinase 2), VEGFR2 
(vascular endothelial growth factor receptor 2), AnnexinV, SMA 
and PDGFRβ (Supplementary Fig. S4b) and, on in vitro culture, 
YFP +  cells maintain pericyte markers such as NG2, SMA and 
desmin (Supplementary Fig. S4c–e).
To further investigate the myogenic differentiation process of 
AP-derived pericytes and its relation with muscles expressing Pax3 
in vivo, we sorted YFP +  cells from forelimb muscles (whose sat-
ellite cells are known to express Pax3) and hindlimb muscles of 
Tg:TN-AP-CreERT2:R26R-EYFP mice, either 1 and 8 weeks after 
last tamoxifen injection. At different times in culture, we followed 
Pax7, Pax3 and Myf5 expression by immuno-fluorescence. A high 
percentage of YFP +  cells, sorted 1 week after last tamoxifen injec-
tion, was found to express Pax3; 60% of the total YFP +  cells from 
the forelimb, and 25% from hindlimb (Supplementary Fig. 5a–c). 
Pax3 expression rapidly decreases after 48 h in culture, when Myf5 
expression first appears. Pax7 is never expressed in culture, indi-
cating that the myogenic differentiation of AP-derived pericytes, 
in culture, is Pax7-independent (Supplementary Fig. S5d–f). On 
the other hand, the protein expression profile of YFP +  cells sorted 
from Tg:TN-AP-CreERT2:R26R-EYFP, 8 weeks after last tamoxifen 
injection, is different and comparable to the typical satellite cells 
profile. In fact, Pax7 is expressed in many cells (50%) until 72 h 
in culture and decreases thereafter with a concomitant increase of 
Myf5 expression (Supplementary Fig. S5g–i) At this stage Pax3 is 
present at a low frequency (below 10%) only in cells obtained from 
forelimb muscles. Quantification of myogenic gene expression 
in YFP +  cells during time in culture, is shown in Supplementary 
Figure S5j,k, respectively, 1 week or 8 weeks after tamoxifen injec-
tion. Direct quantitative comparisons between Pax3 and Pax7 is not 
possible since Pax3 is also expressed in some smooth muscle cells25 
whereas Pax7 is not. In both cases, YFP +  cells, obtained 1 week or 
8 weeks after tamoxifen injection, begin to form myotubes after 5 
days in culture. Each experiment was repeated three times with six 
mice each; polyclonal populations were analysed after 24 and 48 h 
in culture, whereas single cell-derived clones were analysed at later 
time points, when clones became clearly identifiable.
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Figure 4 | Generation of satellite cells from AP + -derived cells during mouse growth. (a) Immunohistochemistry on Tg:TN-AP-CreERT2:R26R Pectoralis 
muscle sections, 1 week after tamoxifen injection, stained for β-gal (blue) and anti-Pax7 (brown). The majority of Pax7 +  cells are β-gal negative  
(brown arrows), whereas vessels are blue (blue arrows). only few double-positive cells are detectable (green arrow). Insets show high magnification. 
(b) Immunohistochemistry on Tg:TN-AP-CreERT2:R26R Pectoralis muscle sections 1 month after last tamoxifen injection stained for β-gal (blue) and Pax7 
(brown). several Pax7 + /β-gal +  satellite cells were detected (green arrows) together with β-gal +  fibres. Insets show high magnification. (c–f) TA muscle 
section of Tg:TN-AP-CreERT2:R26R mouse, 2 months after tamoxifen injection. A Pax7 +  (green) satellite cell also expresses β-gal (red) (arrows); the 
satellite cell is associated to a β-gal-negative fibre. Laminin is stained in magenta. scale bar, 100 µm. (g) Pax7 + /β-gal +  satellite cells counted on the total 
number of Pax7 +  satellite cells, in different muscles and at different time points after tamoxifen induction: 1 week (pale blue), 2 weeks (dark blue),  
3 weeks (pale grey), 4 weeks (dark grey). number of experimental animals: n = 5. Error bars indicate standard deviation. Results were assessed for 
statistical significance by student’s t-test (unpaired, two-tailed) and differences were considered statistically significant at P < 0.05. Asterisks in the 
histogram indicate the different P values: **P < 0.01 and ***P < 0.001. (h) Total number of satellite cells for microscopic field (~0.5 mm2) at different time 
points after tamoxifen induction in Pectoralis muscle. Blue bars indicate the number of Pax7 + /β-gal −  satellite cells; red bars indicate the number of 
Pax7 + /β-gal +  satellite cells. The total number of Pax7 +  cells decreases with time, whereas the number of double-positive Pax7 + /β-gal +  cells increases 
until 3 weeks after tamoxifen induction, remaining constant afterwards. number of experimental animals: n = 5. Error bars indicate standard deviation. 
Results were assessed for statistical significance by student’s t-test (unpaired, two-tailed) and differences were considered statistically significant at 
P < 0.05. Asterisk in the histogram indicates P value: *P < 0.05.
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Discussion
Postnatal myogenesis is mainly due to proliferation of juvenile 
satellite cells that contribute to the development of skeletal mus-
cle by fusing with growing myofibres, and, to its regeneration, 
by repairing or replacing damaged or degenerated myofibres26. 
Nevertheless, in the last ten years, evidence has accumulated that 
other progenitors can contribute to skeletal muscle regeneration 
either by direct fusion or by entering the satellite cell pool6–8,27–36. 
When identified, the anatomical niche of these cells has been often 
associated with blood vessels (endothelial cells, pericytes and also 
haematopoietic cells). However, the embryonic origin of these 
unorthodox myogenic cells and their lineage relationship with 
satellite cells remain unknown. It was similarly unclear whether 
skeletal myogenesis is one possible developmental option of these 
non-myogenic progenitors, or whether it represents the artifi-
cial consequence of cell transplantation that, through occasional 
fusion with regenerating fibres, exposes the donor cell nucleus to 
the dominant effect of MyoD.
In this work, we used Tg:TN-AP-CreERT2 mice to follow the 
fate of vessel-associated cells during postnatal muscle growth. AP 
is broadly expressed in many pre- and postnatal tissues, and in dif-
ferent cell types such as osteoblasts37, embryonic stem cells38, bone 
marrow stroma cells39, liver and kidney cells40, granulocytes41 and B 
cells42; however, in postnatal mouse striated muscles, AP is expressed 
only by vessel-associated cells, in both endothelial cells and peri-
cytes, as previously reported9,14–16, and exhaustively confirmed 
in this work through a variety of histochemical and immuno-
chemical methods. Most importantly, by using virtually all possi-
ble experimental approaches, we demonstrated that both AP and 
Cre expression are invariably absent in quiescent satellite cells, as 
well as in proliferating and differentiating myogenic cells in vitro 
or in vivo, even after cardiotoxin-induced damage. These prelimi-
nary results rule out the possibility of inappropriate lineage tracing, 
because of undetected expression in different cell types resident in 
skeletal muscle, and allowed us to investigate the fate of AP-derived 
vascular cells in growing postnatal skeletal muscle. A time course 
of reporter gene expression showed that, beside their expected con-
tribution to the micro-vascular wall, pericytes, but not endothelial 
cells (as revealed by an endothelial-specific CreERT2 mouse), con-
tribute to the growth of a minor but significant percentage of mus-
cle fibres. Moreover, many AP-derived cells enter the satellite cell 
pool, with a relatively fast kinetics during the first month of post-
natal life, suggesting that they also contribute to subsequent muscle 
regeneration. Indeed, conditions that trigger acute or chronic skel-
etal muscle regeneration, such as cardiotoxin injection or muscular 
dystrophy, increase dramatically AP +  cell contribution to skeletal 
myogenesis (up to five times in the area of acute regeneration and 
three times in dystrophic muscle). These results show that AP + 
pericytes respond to pathological conditions, and, thus, they may 
serve as a tool for the cell therapy of dystrophic patients and justify 
the rationale for a clinical trial, with human AP +  pericytes, that is 
currently running in our Institution.
We found the highest number of β-gal +  fibres and β-gal +  sat-
ellite cells in muscles where Pax3 is expressed postnatally, such as 
forelimb muscles and Diaphragm43. Furthermore, we observed that 
these AP +  vessel-associated cells express Pax3 in young animals 
(D.A., C.D. and C.G.; unpublished data) and that YFP +  cells, iso-
lated 1 week after tamoxifen injection, express Pax3, and not Pax7, 
in culture. On the other hand, we have clearly shown that, during 
mouse growth, AP-derived pericytes become real satellite cells and 
acquire Pax7 +  expression in vivo, under the basal lamina and when 
isolated in vitro, two months after tamoxifen induction. It was previ-
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Figure 5 | AP +  pericytes contribution to skeletal muscle after acute injury. (a,b) Whole-mount X-Gal staining of Tg:TN-AP-CreERT2:R26R untreated 
(a) or cardiotoxin-treated (b) TA muscle showing a dramatic increase in the number of β-gal + , regenerated fibres. (c) section of muscles shown in (b), 
stained for β-gal and H&E; β-gal +  centrally nucleated fibres are visible. (d) The percentage of β-gal +  fibres is increased from 0.9% in untreated TA muscle 
(grey histogram) to 5.07% in cardiotoxin-treated TA muscle (black histogram). In Gastrocnemius (GAs), the percentage of β-gal +  fibres is increased from 
1.6% in untreated leg (grey histogram) to 11.15% in cardiotoxin-treated (black histogram). number of experimental animals: n = 5; error bars indicate 
standard deviation. Results were assessed for statistical significance by student’s t-test (unpaired, two-tailed) and differences were considered statistically 
significant at P < 0.05. Asterisks in the histogram indicate the different P values: **P < 0.01 and ***P < 0.001. (e) TA section of Tg:TN-AP-CreERT2:RNZG mice 
injected with tamoxifen at P6–P8, treated with cardiotoxin at 3 weeks and killed 3 weeks after damage. many regenerating, centrally nucleated fibres are 
present (arrows); high magnification is shown in the inset. (f,g) TA sections of Tg:TN-AP-CreERT2:RNZG mice injected with two rounds of cardiotoxin and 
killed 24 h (f) or 3 weeks (g) after the second injury (details in the text). scale bar, 100 µm.
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ously demonstrated that during embryogenesis Pax3 +  progenitors 
of the dermomyotome give rise not only to myogenic cells, but also 
to several other mesoderm cell types, including dermal fibroblasts, 
endothelial cells44,45, and, notably, to pericytes and smooth muscle 
of the dorsal aorta25. Thus, whereas all satellite cells appear to origi-
nate from somites2, the data presented here are not in contrast with 
this evidence, because other mesoderm progenitors, such as Pax3-
expressing pericytes, also originate from somites. These progenitors 
may directly differentiate into skeletal muscle while expressing Pax3 
(at least in vitro), and this occurs more frequently in postnatal fore-
limb muscles where Pax3 is more abundant; alternatively, they may 
enter the satellite cells pool and activate Pax7 expression.
AP +  cell contribution to skeletal muscle mainly occurs during 
the first month of postnatal growth and becomes sporadic in adult 
mice even in regenerating myofibres after cardiotoxin-induced 
muscle damage. Probably only during perinatal growth AP-derived 
pericytes can contribute to skeletal myogenesis and enter the 
satellite cells pool, in response to a major recruitment of myogenic 
cells to the maturing muscle fibres. Thus, it is conceivable that this 
contribution may be higher during prenatal development but, 
unfortunately, widespread expression of AP at this stage precludes 
this analysis.
Very recently, three reports46–48 showed that selective ablation 
of Pax7-expressing satellite cells during adult life permanently 
hampers subsequent attempts to regenerate skeletal muscles, 
leading to the conclusion that no other endogenous cell types may 
substitute for satellite cells. These results are not in contradiction 
with those reported here for the following reasons: the ablation 
of Pax7 +  satellite cells was carried out in adult mice, at an age 
when the contribution of AP +  pericyets to muscle regenera-
tion becomes negligible. It is also possible that satellite cells are 
required to induce other cell types to adopt a myogenic fate, as 
suggested by Sambasivan et al.48
20
18
16
14
12
10
%
 O
f β
-
ga
l+
 fi
br
es
8
6
4 ***
***
***
***
***
2
0
TA GAS TRIC PECT DIAPH
αSGKO
αSGKO
αSG+/–
Figure 6 | AP +  pericytes contribution to skeletal muscle during chronic 
regeneration. (a,b) Triceps muscles of Tg:TN-AP-CreERT2:R26R:αSGKO  
(a) or Tg:TN-AP-CreERT2:R26R:αSG + / −  (b) mice, injected with tamoxifen 
at P6–P8, killed two months later and stained for β-gal activity. many  
β-gal +  fibres can be detected in the dystrophic muscle. (c) muscle 
sections of Tg:TN-AP-CreERT2:R26R:αSGKO shown in (a) stained for β-gal 
and H&E. scale bar, 100 µm. (d) Percentage of β-gal +  fibres detected in 
the dystrophic muscles. Grey bars indicate αSG + / −  background; black 
bars indicate αSGKO background. number of experimental animals: n = 5; 
error bars indicate standard deviation. Results were assessed for statistical 
significance by student’s t-test (unpaired, two-tailed) and differences were 
considered statistically significant at P < 0.05. Asterisks in the histogram 
indicate the P value: ***P < 0.001. GAs, Gastrocnemius; TRIC, Triceps; PECT, 
Pectoralis; DIAPH, Diaphragm.
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Figure 7 | Endothelial cells do not contribute to growing or regenerating muscle. (a) Ve-cadherin(PAC)-CreRT2:R26R Pectoralis muscle stained for β-gal 
(blue) and Pecam (brown) 3 days after tamoxifen injections (P6–P8). (b,c) Whole mount X-Gal staining of Ve-cadherin(PAC)-CreRT2:R26R Diaphragm (b) 
and Pectoralis (c) 2 months after tamoxifen injections (P6–P8). β-gal +  vessels are clearly visible. (d,e) TA muscle sections of Ve-cadherin(PAC)-CreERT2:
R26R mouse 1 week (d) and 2 months (e) after tamoxifen injection, stained for β-gal (blue) and anti-Pax7 (brown). no double-positive cells are present.  
(f,g) TA muscle sections of Ve-cadherin(PAC)-CreERT2:R26R mice 1 month after cardiotoxin injection (CTX) (g) and contralateral muscle (f), stained for 
β-gal and H&E. no β-gal +  fibres are detected. scale bar, 20 µm.
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In conclusion, we have demonstrated that vascular pericytes, 
resident in skeletal muscle, are bi-potent (as confirmed by clonal 
analysis), as they contribute to both the smooth muscle layer of 
blood vessels and skeletal muscle fibre development, including 
the satellite cell pool, during unperturbed, postnatal growth of 
the mouse. It is still unknown how this choice is regulated in vivo, 
although it is plausible that signals emanating from neighbour 
muscle fibres or endothelium may direct the cells to a skeletal or to 
a smooth muscle fate, respectively.
Methods
Mice generation and genotyping. To generate Tg:TN-AP-CreERT2 mice the Cre 
recombinase fused with estrogen receptor (CreERT2) was cloned in a pGEM-T Easy 
Vector, between two fragments homologous to TN-AP gene in the starting coding 
region ATG upstream region. The construct was inserted into a bacterial artificial 
chromosome (BAC) 240 kbp clone (RP23 RP23-400F8 (Start: 137,302,861 and End: 
137,529,460)) by homologous recombination in bacteria (spanning from 177 kbp 
upstream of the ATG, and covering most of the coding region). Molecular analysis dem-
onstrated the correct insert of the construct into the BAC (Supplementary Fig. S2b,c). 
Digestion by BamHI shows the generation of an extra 2.8 kbp band and the absence 
of an 8 kbp band in the electroporated BAC compared with the unelectroporated 
one. Injection of the BAC into fertilized eggs generated a total of seven independent 
transgenic lines that were tested by crossing with the R26R reporter mouse49. Three lines 
were found to express beta-galactosidase and were used for subsequent experiments.
Mice were kept heterozygous and genotyped by FW primer mapping on TN-AP 
sequence (FWTN-AP cgtctagatgagcctagggctggctggagcacag) and RW primer map-
ping on Cre sequence (RWCRE cagccaccagcttgcatga), generating a 1,400 bp band.
Genotyping strategies of other mice, including Pax7 − / −  mutant mice50, 
Myf5nlacZ/ +  mice19, Ve-Cadherin-(PAC)CreERT2 (ref. 12), TN-APβgeo/ +  (ref. 16) have 
been published. To test our transgenic model, we used three different reporter 
mice: R26R49 that express cytoplasmic β-gal; R26NZG21 that express nuclear β-gal and 
R26R-EYFP 51 that express cytoplasmic YFP. Control mice C57/BLJ6 from Jackson 
laboratory were used. All experiments were performed under internal regulations 
for animal care and handlings (IACUC 355). Both males and females were used for 
experiments and they were equally distributed between control and treated groups 
to avoid gender variations in muscle mass.
Tamoxifen injection and cardiotoxin treatment. Young animals were injected 
subcutaneously with 0.25 mg of tamoxifen, diluted in corn oil, (SIGMA T5648-1G) 
for 3 consecutive days at 6, 7 and 8 days after birth. Adult animals were treated for 
3 consecutive days with 2 mg of tamoxifen by intraperitoneal injection. For the 
injury protocol, 25 µl of 100 µM cardiotoxin from Naja mossambica mossambica 
(SIGMA C9759) were injected directly into skeletal muscle.
X-gal staining and immunohistochemistry. Dissected muscles were fixed with 
paraformaldehyde (PFA) 4% and 0.25% glutaraldehyde for 30 min at 4 °C. After 
incubation in X-gal solution O/N at 37 °C, they were washed and dehydrated 
with increasing sucrose concentration (10–20 and 30%) for 20 min and then  
frozen within OCT. Eight µm cryostats sections were used for immunohisto-
chemistry and stained with H&E when necessary. The endogenous peroxidases 
were blocked by H2O2 30% in methanol for 30 min. The sections were then incu-
bated with PBS 0.2% Triton 1% BSA for 30 min and with 10% donkey serum for 
30 min. Primary antibody incubation was followed by secondary biotinilated an-
tibody (Dako) and ABC kit (Vector Laboratories, PK-6100), enzymatic reaction  
with DAB (Sigma) was followed under microscope and stopped after the  
appropriated time.
-gal activity measurement. Muscles were homogenized in buffer (0.25 M Tris 
pH 7.8, PMSF 1 mM), centrifuged at 15,000 g×10 min at 4 °C, and extracted pro-
teins were subsequently quantified by spectrophotometer with DC protein Assay 
(Biorad, 500-0114). 100 µg of protein were incubated with 500 µl of Z Buffer pH7 
(60 mM Na2HPO4 40 mM NaH2PO4 10 mM KCl, 1 mM MgSO4, 50 mM b-Mercap-
toethanol) and 100 µl of ONPG (o-nitrophenyl-b-d-galactoside) 4 mg ml − 1 at 37 °C 
for 2.5 h. The reaction was blocked with 250 µl of Na2CO3 and the level of β-gal 
activity was evaluated by reading the OD420 at the spectrophotometer. To quantify 
the proportion of β-gal +  fibres in different muscles of Tg:TN-AP-CreERT2:R26R 
mice, we created a standard curve by mixing different proportions (from 0.1 to 
50%) of muscle homogenates derived from wild-type and CMV-Cre-R26 mice. 
The proportion of β-gal activity only due to β-gal-positive fibres was calculated by 
subtracting the activity measured in muscles from Tg:TN-AP-CreERT2:R26R mice 
injected with tamoxifen and killed 1 week later, when the β-gal signal is present 
only in vessel-associated cells.
Alkaline phosphatase reaction. Different kits for AP enzymatic detection were 
used (see below) to exploit different reaction colours. Muscle sections were fixed 
with PFA 4% at 4 °C for 10 min and, after 3 washes, incubated with BCIP-NBT kit 
(Roche, 12296226 and 12329020) in an alkaline buffer (NaCl 100 mM, Tris 100 mM 
PH 9.5, MgCl2 50 mM, Tween 0.1%) for 20 min in the dark, or with PermaRed/AP 
(Histo-Line laboratories, K049) for 20 min. Moreover, AP substrate kit from Vector 
(SK-5100) were used and visualized by confocal microscopy (Leica) at 456 nm, 
along with other immuofluorescent antibodies.
Immunofluorescence and antibodies. Frozen sections and cultured cells were 
fixed with PFA 4% at 4 °C for 10 min, washed 3× with Triton 0.2% BSA 1% in PBS, 
and incubated with the same buffer for 30 min, followed by 10% Donkey serum for 
30 extra min. Primary antibody was incubated for 1 h at room temperature or O/N 
at 4 °C in the same buffer. Samples were washed 3 times and then incubated with 
secondary antibodies (Alexa Fluor 488-594-546 or 647, Invitrogen) for 1 h at RM, 
washed 3 times and then mounted and examined under epifluorescence or  
confocal Leica microscope.
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Figure 8 | Myogenic potential of isolated AP-derived YFP +  cells. (a) FACs analysis with a gate selected to sort YFP +  cells. (b) Relative frequency of 
double-positive YFP + /Pax7 +  cells as % of the total YFP +  cells, obtained immediately after sorting, at different time points after tamoxifen induction and 
after cardiotoxin injection (CTX). Error bars indicate standard deviation. Results were assessed for statistical significance by student’s t-test (unpaired, 
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(c–e) Freshly isolated YFP +  cells were stained with anti-GFP antibody (green) and anti-Pax7 (red). scale bar, 20 µm (f) skeletal myogenic YFP +  clone, 
stained with anti-myHC (red), anti-GFP (green) and DAPI (blue). (g) smooth myogenic YFP +  clone, stained with anti-smA (red), anti-GFP (green) and 
DAPI (blue). (h,i) smooth myogenic (h) and mixed (i) YFP +  clones stained for anti-myHC (green), anti-sm22α (magenta) and DAPI (blue). We counted 
2 double-positive clones on a total number of 114 clones scored. scale bars, 40 µm.
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The immunofluorescence assay was carried out with the following antibodies: 
rabbit anti-β-galactosidase at 1:100 dilution (Chemicon, AB986), rabbit anti-β-gal 
at 1:1,000 (MPCappel 559762) and mouse anti-β-gal at 1:200 (Promega Z3783);  
rabbit anti-laminin at 1:300 (Sigma, L9393) or chicken anti-laminin at 1:500 
(Abcam, Ab14055); anti- NG2 1:200 (Chemicon, AB5320) or donated from  
W. Stallcup, at 1:100; anti-Pecam at 1:2 (gift from Elisabetta Dejana); anti-Pax7 
at 1:2 (DHSB); anti-smooth muscle actin at 1:200 (Sigma, A2547); anti-SM22α 
at 1:100 (Abcam); anti-MyHC at 1:2 (MF20 DHSB); anti-GFP 1:300 (Chemicon, 
AB3080); anti-Ki67 at 1:500 (Novo Castra, NCL-Ki67p), anti-PDGFRβ at 1:100 
(from W. Stallcup), anti-AP at 1:100 (R&D); anti Pax3 at 1:2 (DHSB); anti MyoD at 
1:100 (Dako).
Cell sorting. Dissected muscles were cut in small pieces and digested by colla-
genase D 0.1% (Roche, 1088866) and Trypsin 0.25% (Gibco, 15090-046) for 20 min 
at 37 °C, 2 or 3 cycles. After spin and filtration, the cells were collected in DMEM, 
20%FBS, 2 mM EDTA, 20 mM HEPES or PBS 2% FBS, 2 mM EDTA when staining 
with SM/C2.6 (a gift from S. Takeda).
Cell Sorting was carried out in MoFLo System (DAKO); sorted cells were  
either cloned in 96 wells or collected for RNA extraction. FACS analysis was  
performed by Canto (BD); data were analysed by FACSDiva software (BD).
Sorted cells were cultured with DMEM (Sigma) 20%FBS on (low factor) 
Matrigel (BD, 354248) coated wells, in low (3%) oxygen incubator.
RT–PCR and quantitative real-time PCR. The RNA from sorted cells was collect-
ed by RNeasy mini (or micro) kit (Qiagen, 74104 and 74004) and converted into 
double-strand complementary DNA with the Superscript VILO cDNA systhesis kit 
(Invitrogen, 11754-050), according to the manufacturer’s instructions. Real-time 
quantitative PCR analysis was carried out on cDNA from isolated cells by using 
an Mx3000P real-time PCR detection system (Stratagene). Each cDNA sample 
was amplified in duplicate by using the Express SYBR GreenER qPCR Supermix 
(Invitrogen, 11784-200). 
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